1049 related articles for article (PubMed ID: 22309967)
21. Syndromes of Thrombotic Microangiopathy.
Shatzel JJ; Taylor JA
Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
[TBL] [Abstract][Full Text] [Related]
22. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
Krause M; Fehr J; Gmür J; Keusch G; Frick P; Oelz O
Schweiz Med Wochenschr; 1986 Nov; 116(48):1666-74. PubMed ID: 3798063
[TBL] [Abstract][Full Text] [Related]
23. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
24. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Elliott MA; Nichols WL
Mayo Clin Proc; 2001 Nov; 76(11):1154-62. PubMed ID: 11702904
[TBL] [Abstract][Full Text] [Related]
25. Predictors of response and relapse in a cohort of adults with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a single-institution experience.
Tuncer HH; Oster RA; Huang ST; Marques MB
Transfusion; 2007 Jan; 47(1):107-14. PubMed ID: 17207238
[TBL] [Abstract][Full Text] [Related]
26. [Thrombotic microangiopathy in adults].
Barrientos GJ; Michelangelo H
Medicina (B Aires); 2006; 66(4):289-95. PubMed ID: 16977962
[TBL] [Abstract][Full Text] [Related]
27. Analyses of data of patients with Thrombotic Microangiopathy in the WAA registry.
Mörtzell M; Berlin G; Nilsson T; Axelsson CG; Efvergren M; Audzijoni J; Griskevicius A; Ptak J; Blaha M; Tomsova H; Liumbruno GM; Centoni P; Newman E; Eloot S; Dhondt A; Tomaz J; Witt V; Rock G; Stegmayr B
Transfus Apher Sci; 2011 Oct; 45(2):125-31. PubMed ID: 21903476
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of thrombotic microangiopathies].
Debourdeau P; Zammit C; Souleau B; Védrine L; Farge-Bancel D
Ann Med Interne (Paris); 1999 Sep; 150(5):374-87. PubMed ID: 10544747
[TBL] [Abstract][Full Text] [Related]
29. Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange.
Wyllie BF; Garg AX; Macnab J; Rock GA; Clark WF;
Br J Haematol; 2006 Jan; 132(2):204-9. PubMed ID: 16398654
[TBL] [Abstract][Full Text] [Related]
30. [Clinical management of hemolytic-uremic syndrome and thrombotic-thrombocytopenic purpura].
Keller F; Schwarze H; Schwarz A
Wien Klin Wochenschr; 1994; 106(19):603-7. PubMed ID: 7998406
[TBL] [Abstract][Full Text] [Related]
31. Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura?
Fakhouri F; Frémeaux-Bacchi V
Nat Clin Pract Nephrol; 2007 Dec; 3(12):679-87. PubMed ID: 18033227
[TBL] [Abstract][Full Text] [Related]
32. [Thrombotic microangiopathies].
Starck M; Wendtner CM
Dtsch Med Wochenschr; 2014 Oct; 139(40):1993-6. PubMed ID: 25254393
[No Abstract] [Full Text] [Related]
33. [Thrombotic microangiopathies].
Moulinier C; Veyradier A; Rondeau E; Coppo P;
Rev Prat; 2013 Feb; 63(2):163-70. PubMed ID: 23513771
[TBL] [Abstract][Full Text] [Related]
34. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Bittencourt CE; Ha JP; Maitta RW
PLoS One; 2015; 10(5):e0127744. PubMed ID: 26000799
[TBL] [Abstract][Full Text] [Related]
35. TTP/HUS and prognosis: the syndrome and the disease(s).
Forzley BR; Clark WF
Kidney Int Suppl; 2009 Feb; (112):S59-61. PubMed ID: 19180139
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.
Kim JW; Kim I; Oh KH; Yoon SS; Oh MD; Song YW; Heo DS; Bang YJ; Han KS; Han JS; Park S; Kim BK
Hematology; 2011 Mar; 16(2):73-9. PubMed ID: 21418736
[TBL] [Abstract][Full Text] [Related]
37. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: evaluation, management, and long-term outcomes experience of the Oklahoma TTP-HUS Registry, 1989-2007.
George JN
Kidney Int Suppl; 2009 Feb; (112):S52-4. PubMed ID: 19180137
[TBL] [Abstract][Full Text] [Related]
38. [Thrombotic microangiopathy (DIC,TTP and HUS)--recent advances in pathogenesis and management].
Saito H
Nihon Rinsho; 1993 Jan; 51(1):5-10. PubMed ID: 8433528
[No Abstract] [Full Text] [Related]
39. [Thrombotic microangiopathy : Relevant new aspects for intensive care physicians].
Gaggl M; Aigner C; Sunder-Plassmann G; Schmidt A
Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):434-9. PubMed ID: 27255224
[TBL] [Abstract][Full Text] [Related]
40. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.
Nakayama S; Hirashio S; Yorishima H; Doi T; Yoshida Y; Matsumoto M; Masaki T
CEN Case Rep; 2019 Nov; 8(4):266-270. PubMed ID: 31177384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
